Asterias Biotherapeutics, Inc. To Present Phase I Clinical Data At The 17th Annual Meeting Of The American Society Of Gene & Cell Therapy
5/13/2014 7:48:30 AM
BioTime, Inc. (NYSE MKT: BTX) and its subsidiary Asterias Biotherapeutics, Inc. today announced that Jane S. Lebkowski, PhD, President, Research & Development of Asterias, will present at the 17th Annual Meeting of the American Society of Gene & Cell Therapy taking place May 20-24, 2014 in Washington, DC.
Help employers find you! Check out all the jobs and post your resume.
comments powered by